Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire
Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 – Technological Advancements in Diagnostics | Technavio - Business Wire Posted: 31 Oct 2019 06:30 AM PDT LONDON--( BUSINESS WIRE )--Technavio's report on human papillomavirus (HPV) therapeutics market is expected to grow by $1.75 billion during 2019-2023 . Currently, the approved vaccines for HPV therapies are administered through the parenteral route, which needs an invasive infusion of therapeutics into the body. To meet the need for novel drug delivery systems, vendors are working on developing oral vaccines for HPV. These vaccines are developed with nano or microparticles around the surface to enhance target delivery. This will lead to a rise in patient adherence to the treatment and attract more people to accept the vaccines. Read ...